Global Oseltamivir Phosphate Capsules 麻豆原创 Research Report 2024

Publication ID:

PB503247233

Publication Date:

March 21, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Oseltamivir Phosphate Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Oseltamivir Phosphate Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oseltamivir Phosphate Capsules.
Report Scope
The Oseltamivir Phosphate Capsules market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oseltamivir Phosphate Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oseltamivir Phosphate Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Natco Pharma
Roche Pharma
HEC
Zentiva
Taj Pharma
Sawai Pharmaceutical
MSN Laboratories
Hetero Healthcare
Cipla
Amneal Pharmaceuticals
Brilliant Pharmaceutical
BrightGene
Kelun Pharmaceutical
Qilu Pharmaceutical
CSPC
Zhijun Pingshan
Zhongxi Sunve
Segment by Type
30mg
45mg
75mg
Segment by Application
Influenza Treatment
Influenza Prevention
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oseltamivir Phosphate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oseltamivir Phosphate Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Oseltamivir Phosphate Capsules 麻豆原创 Overview
1.1 Product Overview and Scope of Oseltamivir Phosphate Capsules
1.2 Oseltamivir Phosphate Capsules Segment by Type
1.2.1 Global Oseltamivir Phosphate Capsules 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 30mg
1.2.3 45mg
1.2.4 75mg
1.3 Oseltamivir Phosphate Capsules Segment by Application
1.3.1 Global Oseltamivir Phosphate Capsules 麻豆原创 Value by Application: (2024-2030)
1.3.2 Influenza Treatment
1.3.3 Influenza Prevention
1.4 Global Oseltamivir Phosphate Capsules 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Oseltamivir Phosphate Capsules Revenue 2019-2030
1.4.2 Global Oseltamivir Phosphate Capsules Sales 2019-2030
1.4.3 Global Oseltamivir Phosphate Capsules 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oseltamivir Phosphate Capsules 麻豆原创 Competition by Manufacturers
2.1 Global Oseltamivir Phosphate Capsules Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Oseltamivir Phosphate Capsules Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Oseltamivir Phosphate Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Oseltamivir Phosphate Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oseltamivir Phosphate Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oseltamivir Phosphate Capsules, Product Type & Application
2.7 Oseltamivir Phosphate Capsules 麻豆原创 Competitive Situation and Trends
2.7.1 Oseltamivir Phosphate Capsules 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oseltamivir Phosphate Capsules Players 麻豆原创 Share by Revenue
2.7.3 Global Oseltamivir Phosphate Capsules 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oseltamivir Phosphate Capsules Retrospective 麻豆原创 Scenario by Region
3.1 Global Oseltamivir Phosphate Capsules 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oseltamivir Phosphate Capsules Global Oseltamivir Phosphate Capsules Sales by Region: 2019-2030
3.2.1 Global Oseltamivir Phosphate Capsules Sales by Region: 2019-2024
3.2.2 Global Oseltamivir Phosphate Capsules Sales by Region: 2025-2030
3.3 Global Oseltamivir Phosphate Capsules Global Oseltamivir Phosphate Capsules Revenue by Region: 2019-2030
3.3.1 Global Oseltamivir Phosphate Capsules Revenue by Region: 2019-2024
3.3.2 Global Oseltamivir Phosphate Capsules Revenue by Region: 2025-2030
3.4 North America Oseltamivir Phosphate Capsules 麻豆原创 Facts & Figures by Country
3.4.1 North America Oseltamivir Phosphate Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oseltamivir Phosphate Capsules Sales by Country (2019-2030)
3.4.3 North America Oseltamivir Phosphate Capsules Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oseltamivir Phosphate Capsules 麻豆原创 Facts & Figures by Country
3.5.1 Europe Oseltamivir Phosphate Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oseltamivir Phosphate Capsules Sales by Country (2019-2030)
3.5.3 Europe Oseltamivir Phosphate Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oseltamivir Phosphate Capsules 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Oseltamivir Phosphate Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oseltamivir Phosphate Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Oseltamivir Phosphate Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oseltamivir Phosphate Capsules 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Oseltamivir Phosphate Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oseltamivir Phosphate Capsules Sales by Country (2019-2030)
3.7.3 Latin America Oseltamivir Phosphate Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oseltamivir Phosphate Capsules 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Oseltamivir Phosphate Capsules 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oseltamivir Phosphate Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oseltamivir Phosphate Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oseltamivir Phosphate Capsules Sales by Type (2019-2030)
4.1.1 Global Oseltamivir Phosphate Capsules Sales by Type (2019-2024)
4.1.2 Global Oseltamivir Phosphate Capsules Sales by Type (2025-2030)
4.1.3 Global Oseltamivir Phosphate Capsules Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Oseltamivir Phosphate Capsules Revenue by Type (2019-2030)
4.2.1 Global Oseltamivir Phosphate Capsules Revenue by Type (2019-2024)
4.2.2 Global Oseltamivir Phosphate Capsules Revenue by Type (2025-2030)
4.2.3 Global Oseltamivir Phosphate Capsules Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Oseltamivir Phosphate Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oseltamivir Phosphate Capsules Sales by Application (2019-2030)
5.1.1 Global Oseltamivir Phosphate Capsules Sales by Application (2019-2024)
5.1.2 Global Oseltamivir Phosphate Capsules Sales by Application (2025-2030)
5.1.3 Global Oseltamivir Phosphate Capsules Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Oseltamivir Phosphate Capsules Revenue by Application (2019-2030)
5.2.1 Global Oseltamivir Phosphate Capsules Revenue by Application (2019-2024)
5.2.2 Global Oseltamivir Phosphate Capsules Revenue by Application (2025-2030)
5.2.3 Global Oseltamivir Phosphate Capsules Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Oseltamivir Phosphate Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Natco Pharma
6.1.1 Natco Pharma Corporation Information
6.1.2 Natco Pharma Description and Business Overview
6.1.3 Natco Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Natco Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.1.5 Natco Pharma Recent Developments/Updates
6.2 Roche Pharma
6.2.1 Roche Pharma Corporation Information
6.2.2 Roche Pharma Description and Business Overview
6.2.3 Roche Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.2.5 Roche Pharma Recent Developments/Updates
6.3 HEC
6.3.1 HEC Corporation Information
6.3.2 HEC Description and Business Overview
6.3.3 HEC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HEC Oseltamivir Phosphate Capsules Product Portfolio
6.3.5 HEC Recent Developments/Updates
6.4 Zentiva
6.4.1 Zentiva Corporation Information
6.4.2 Zentiva Description and Business Overview
6.4.3 Zentiva Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zentiva Oseltamivir Phosphate Capsules Product Portfolio
6.4.5 Zentiva Recent Developments/Updates
6.5 Taj Pharma
6.5.1 Taj Pharma Corporation Information
6.5.2 Taj Pharma Description and Business Overview
6.5.3 Taj Pharma Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taj Pharma Oseltamivir Phosphate Capsules Product Portfolio
6.5.5 Taj Pharma Recent Developments/Updates
6.6 Sawai Pharmaceutical
6.6.1 Sawai Pharmaceutical Corporation Information
6.6.2 Sawai Pharmaceutical Description and Business Overview
6.6.3 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sawai Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.6.5 Sawai Pharmaceutical Recent Developments/Updates
6.7 MSN Laboratories
6.6.1 MSN Laboratories Corporation Information
6.6.2 MSN Laboratories Description and Business Overview
6.6.3 MSN Laboratories Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSN Laboratories Oseltamivir Phosphate Capsules Product Portfolio
6.7.5 MSN Laboratories Recent Developments/Updates
6.8 Hetero Healthcare
6.8.1 Hetero Healthcare Corporation Information
6.8.2 Hetero Healthcare Description and Business Overview
6.8.3 Hetero Healthcare Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hetero Healthcare Oseltamivir Phosphate Capsules Product Portfolio
6.8.5 Hetero Healthcare Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Oseltamivir Phosphate Capsules Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Amneal Pharmaceuticals
6.10.1 Amneal Pharmaceuticals Corporation Information
6.10.2 Amneal Pharmaceuticals Description and Business Overview
6.10.3 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amneal Pharmaceuticals Oseltamivir Phosphate Capsules Product Portfolio
6.10.5 Amneal Pharmaceuticals Recent Developments/Updates
6.11 Brilliant Pharmaceutical
6.11.1 Brilliant Pharmaceutical Corporation Information
6.11.2 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.11.3 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Brilliant Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.11.5 Brilliant Pharmaceutical Recent Developments/Updates
6.12 BrightGene
6.12.1 BrightGene Corporation Information
6.12.2 BrightGene Oseltamivir Phosphate Capsules Description and Business Overview
6.12.3 BrightGene Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BrightGene Oseltamivir Phosphate Capsules Product Portfolio
6.12.5 BrightGene Recent Developments/Updates
6.13 Kelun Pharmaceutical
6.13.1 Kelun Pharmaceutical Corporation Information
6.13.2 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.13.3 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kelun Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.13.5 Kelun Pharmaceutical Recent Developments/Updates
6.14 Qilu Pharmaceutical
6.14.1 Qilu Pharmaceutical Corporation Information
6.14.2 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Description and Business Overview
6.14.3 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Qilu Pharmaceutical Oseltamivir Phosphate Capsules Product Portfolio
6.14.5 Qilu Pharmaceutical Recent Developments/Updates
6.15 CSPC
6.15.1 CSPC Corporation Information
6.15.2 CSPC Oseltamivir Phosphate Capsules Description and Business Overview
6.15.3 CSPC Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CSPC Oseltamivir Phosphate Capsules Product Portfolio
6.15.5 CSPC Recent Developments/Updates
6.16 Zhijun Pingshan
6.16.1 Zhijun Pingshan Corporation Information
6.16.2 Zhijun Pingshan Oseltamivir Phosphate Capsules Description and Business Overview
6.16.3 Zhijun Pingshan Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Zhijun Pingshan Oseltamivir Phosphate Capsules Product Portfolio
6.16.5 Zhijun Pingshan Recent Developments/Updates
6.17 Zhongxi Sunve
6.17.1 Zhongxi Sunve Corporation Information
6.17.2 Zhongxi Sunve Oseltamivir Phosphate Capsules Description and Business Overview
6.17.3 Zhongxi Sunve Oseltamivir Phosphate Capsules Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhongxi Sunve Oseltamivir Phosphate Capsules Product Portfolio
6.17.5 Zhongxi Sunve Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oseltamivir Phosphate Capsules Industry Chain Analysis
7.2 Oseltamivir Phosphate Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oseltamivir Phosphate Capsules Production Mode & Process
7.4 Oseltamivir Phosphate Capsules Sales and 麻豆原创ing
7.4.1 Oseltamivir Phosphate Capsules Sales Channels
7.4.2 Oseltamivir Phosphate Capsules Distributors
7.5 Oseltamivir Phosphate Capsules Customers
8 Oseltamivir Phosphate Capsules 麻豆原创 Dynamics
8.1 Oseltamivir Phosphate Capsules Industry Trends
8.2 Oseltamivir Phosphate Capsules 麻豆原创 Drivers
8.3 Oseltamivir Phosphate Capsules 麻豆原创 Challenges
8.4 Oseltamivir Phosphate Capsules 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Natco Pharma
Roche Pharma
HEC
Zentiva
Taj Pharma
Sawai Pharmaceutical
MSN Laboratories
Hetero Healthcare
Cipla
Amneal Pharmaceuticals
Brilliant Pharmaceutical
BrightGene
Kelun Pharmaceutical
Qilu Pharmaceutical
CSPC
Zhijun Pingshan
Zhongxi Sunve

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.